Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Inst. of Medicinal Plant Development STAT3 compound 18q
- Development stage
- Unknown
- Lead developer
- Institute of Medicinal Plants
01
Overview
Inst. of Medicinal Plant Development STAT3 compound 18q: sourced facts only. name: "The CETSA experiment showed that 18q could stabilize the thermal degradation of STAT3, proving that it was a direct inhibitor of STAT3." [PMID:40581301]; target: "The CETSA experiment showed that 18q could stabilize the thermal degradation of STAT3, proving that it was a direct inhibitor of STAT3." [PMID:40581301]; developer: "State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China." [PMID:40581301]
02
Targets
STAT3 (Signal Transducer and Activator of Transcription 3)
Beyond the preview
Go deeper on Inst. of Medicinal Plant Development STAT3 compound 18q.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inst. of Medicinal Plant Development STAT3 compound 18q.